Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR study

Lung Cancer(2025)10.1016/j.lungcan.2025.108802Source: DataRank Database

The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR study is a research paper published in Lung Cancer (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.63)OA: hybridTopics (37)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

David E. Gerber ORCID,Rupesh Kotecha ORCID,Jeffrey P. Ward ORCID,Wallace Akerley ORCID,Lukas Weiß ORCID

Live enrichment

PubMed:41187466 OpenAlex:https://openalex.org/W4415390422

University of Wisconsin Carbone Cancer Center

Novocure UK Limited

National Institutes of Health

FWCI

0.63

Citation Percentile

0.7%

Citation Trend

2026

hybridLicense: cc-by

journalhttps://www.lungcancerjournal.info/article/S0169-5002(25)00694-4/pdf

publisherhttps://www.lungcancerjournal.info/article/S0169-5002(25)00694-4/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0169500225006944?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0169500225006944?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.lungcan.2025.108802

Fields of Study

Radiomics and Machine Learning in Medical ImagingLung Cancer Diagnosis and TreatmentPancreatic and Hepatic Oncology ResearchHumansCarcinoma, Non-Small-Cell LungLung NeoplasmsBody Mass IndexMaleFemaleAgedMiddle AgedDocetaxelComputer SimulationAntineoplastic Combined Chemotherapy ProtocolsNeoplasm Metastasis

MeSH Terms

DocetaxelAgedAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Non-Small-Cell LungComputer SimulationFemaleHumansLung NeoplasmsMaleMiddle AgedNeoplasm MetastasisBody Mass Index

Keywords

Body mass indexLungPhases of clinical researchTherapeutic indexSignificant differenceNon-small cell lung cancerTtfields TherapyImmune Checkpoint InhibitorTumor Treating FieldsPd-l1 Inhibitor